AI-driven Total Parenteral Nutrition Platform

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 6
SponsorTakeoff41, Inc.

About this trial

This study tests whether an artificial intelligence (AI) tool can help doctors order total parenteral nutrition (TPN) for babies in the neonatal intensive care unit (NICU). Premature babies often cannot eat by mouth and need nutrition delivered through an IV. Ordering TPN is complex, time-consuming, and mistakes can happen. This study will test an AI tool that suggests TPN formulas to doctors based on each baby's lab values and health information. Doctors can accept, change, or reject the suggestions at any time. The main goal is to measure how often doctors accept the AI suggestions. The study will also track time to complete TPN orders, weight changes, days on TPN, whether lab values stay in normal ranges, provider satisfaction, and baby health outcomes including complications such as lung disease, brain bleeding, infections, and other conditions common in premature babies. Babies admitted to the NICU who need TPN may participate if their doctors agree to use the tool. Each baby will be in the study while they need TPN, typically about 14 days. The AI tool only makes suggestions and does not replace doctor decision-making. All other care remains the same as standard practice.

Eligibility criteria

Qualifiers

Any newborns or infants requiring total parenteral nutrition in a neonatal ICU that performs daily laboratory tests

6-month old at the time of admission

Any gestational age or birthweight

Any race or sex

Disqualifiers

None

Trial design

Treatments tested in this trial

  • AI-driven total parenteral nutrition (TPN)

Treatment groups

260 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Takeoff41, Inc.

Lead sponsor

Stanford University

Collaborator